Showing results (941-950 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|November 21, 2018
The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signalingJuan Wang, Shumei Ma, Xiuhua Chen, et al.Investigational New Drugs|February 22, 2019
Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case reportKazunori Honda, Shigenori Kadowaki, Kyoko Kato, et al.Investigational New Drugs|March 17, 2019
Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compoundsSara Abdelfatah, Edmond Fleischer, Anette Klinger, et al.Investigational New Drugs|March 30, 2019
Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathwayJiabin Zhou, Genhua Li, Guangkui Han, et al.Investigational New Drugs|April 1, 2019
Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cellsJian-Ning Yao, Xue-Xiu Zhang, Yan-Zhen Zhang, et al.Investigational New Drugs|April 1, 2019
MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathwayYang Liu, Juan Tan, Shuangyan Ou, et al.Investigational New Drugs|March 20, 2019
Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like propertiesJing-De Wu, Ying-Jie Cui, Yi-Gang Zhou, et al.Investigational New Drugs|August 25, 2019
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinomaShunji Takahashi, Motohide Uemura, Tomokazu Kimura, et al.Investigational New Drugs|January 1, 1985
Phase I evaluation of chlorozotocin (NSC-178248): weekly scheduleW J Moriconi, S Taylor, M Slavik, et al.Investigational New Drugs|January 1, 1985
Trimetrexate: a new antifol entering clinical trialsP J O'Dwyer, D D Shoemaker, J Plowman, et al.Pageof 372